CompaniesHenogen

Henogen

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

1,506

By Phase

PHASE1/PHASE2: 1PHASE3: 5PHASE2: 1

By Status

COMPLETED: 6WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
Today
NCT00291954
NCT00291980
NCT00445185
NCT00640497
Hover over trial bars to see details

Recent Trials

NCT00640497Lead Sponsor
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
PHASE1/PHASE2Withdrawn
12 participants
Started: Jan 31, 2010 · Completed: Jan 31, 2012
NCT00480116Lead Sponsor
Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule
PHASE3Completed
450 participants
Started: Jan 31, 2008 · Completed: Apr 30, 2008
NCT00445185Lead Sponsor
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
PHASE3Completed
102 participants
Started: Mar 31, 2007 · Completed: Nov 30, 2009
NCT00291954Lead Sponsor
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
PHASE3Completed
257 participants
Started: Mar 31, 2006 · Completed: Oct 31, 2007
NCT00291980Lead Sponsor
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
PHASE3Completed
185 participants
Started: Mar 31, 2006 · Completed: Oct 31, 2007
View all 7 trials →
Related Companies
Novasep
acquired